GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets
GLPG-0634-CL-131
Phase 1 small_molecule active
Quick answer
GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets for juvenile idiopathic arthritis is a Phase 1 program (small_molecule) at Alfasigma S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alfasigma S.p.A.
- Indication
- juvenile idiopathic arthritis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active